Literature DB >> 28450225

Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.

Punniyakoti T Veeraveedu1, Shoji Sanada2, Keiji Okuda3, Hai Ying Fu3, Takashi Matsuzaki3, Ryo Araki3, Masaki Yamato3, Koubun Yasuda4, Yasushi Sakata3, Tomohiro Yoshimoto4, Tetsuo Minamino5.   

Abstract

BACKGROUND AND
PURPOSE: ST2 is one of the interleukin (IL)-1 receptor family members comprising of membrane-bound (ST2L) and soluble (sST2) isoforms. Clinical trials have revealed that serum sST2 levels predict outcome in patient with myocardial infarction or chronic heart failure (HF). Meanwhile, we and others have reported that ablation of ST2 caused exaggerated cardiac remodeling in both ischemic and non-ischemic HF. Here, we tested whether IL-33, the ligand for ST2, protects myocardium against HF induced by mechanical overload using ligand specific knockout (IL-33-/-) mice. METHODS AND
RESULTS: Transverse aortic constriction (TAC)/sham surgery were carried out in both IL-33 and WT-littermates. Echocardiographic measurements were performed at frequent interval during the study period. Heart was harvested for RNA and histological measurements. Following mechanical overload by TAC, myocardial mRNA expressions of Th1 cytokines, such as TNF-α were enhanced in IL-33-/- mice than in WT mice. After 8-weeks, IL-33-/- mice exhibited exacerbated left ventricular hypertrophy, increased chamber dilation, reduced fractional shortening, aggravated fibrosis, inflammation, and impaired survival compared with WT littermates. Accordingly, myocardial mRNA expressions of hypertrophic (c-Myc/BNP) molecular markers were also significantly enhanced in IL-33-/- mice than those in WT mice.
CONCLUSIONS: We report for the first time that ablation of IL-33 directly and significantly leads to exacerbate cardiac remodeling with impaired cardiac function and survival upon mechanical stress. These data highlight the cardioprotective role of IL-33/ST2 system in the stressed myocardium and reveal a potential therapeutic role for IL-33 in non-ischemic HF.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac remodeling; Fibrosis; Hypertrophy; IL-33; TAC

Mesh:

Substances:

Year:  2017        PMID: 28450225     DOI: 10.1016/j.bcp.2017.04.022

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  19 in total

1.  Human Immunodeficiency Virus-Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study.

Authors:  Justin R Kingery; Parag Goyal; Rahul Hosalli; Myung Hee Lee; Bernard Desderius; Fredrick Kalokola; Abel Makubi; Salama Fadhil; Saidi Kapiga; Dipan Karmali; Daniel Kaminstein; Richard Devereux; Margaret McNairy; Warren Johnson; Daniel Fitzgerald; Robert Peck
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

Review 2.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

3.  Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis.

Authors:  Jessica C Garbern; Jason Williams; Amy C Kristl; Alyyah Malick; Inbal Rachmin; Benjamin Gaeta; Nafis Ahmed; Ana Vujic; Peter Libby; Richard T Lee
Journal:  J Mol Cell Cardiol       Date:  2019-02-11       Impact factor: 5.000

Review 4.  IL-33 in Tumor Immunity: Nothing to Sneeze At.

Authors:  Donye Dominguez; Yi Zhang; Bin Zhang
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

5.  Sclerostin aggravates cardiac remodeling after myocardial infarction by inhibition of Wnt/β-catenin signaling pathway.

Authors:  Shuxin Zheng; Jinyi Wei; Peipei Chen; Fangliang Chen; Guang Yang
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

6.  IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.

Authors:  Se Yun Cheon; Jong Ho Park; Amir H Ameri; Richard T Lee; Rosalynn M Nazarian; Shadmehr Demehri
Journal:  J Invest Dermatol       Date:  2022-03-25       Impact factor: 7.590

7.  TFAM overexpression reduces pathological cardiac remodeling.

Authors:  George H Kunkel; Christopher J Kunkel; Hazel Ozuna; Irina Miralda; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2018-10-23       Impact factor: 3.396

8.  Cardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissue.

Authors:  Richard Pentz; Christoph Kaun; Barbara Thaler; Stefan Stojkovic; Max Lenz; Konstantin A Krychtiuk; Andreas Zuckermann; Kurt Huber; Johann Wojta; Philipp J Hohensinner; Svitlana Demyanets
Journal:  J Cell Mol Med       Date:  2018-09-14       Impact factor: 5.310

9.  Microbiota Modulates Cardiac Transcriptional Responses to Intermittent Hypoxia and Hypercapnia.

Authors:  Dan Zhou; Jin Xue; Yukiko Miyamoto; Orit Poulsen; Lars Eckmann; Gabriel G Haddad
Journal:  Front Physiol       Date:  2021-06-25       Impact factor: 4.566

10.  Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.

Authors:  Ruopeng Tan; Haixu Yu; Xu Han; Yang Liu; Xiaolei Yang; Yun-Long Xia; Xiaomeng Yin
Journal:  Front Cardiovasc Med       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.